We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts Call for Lower GDUFA Fees for Small Generic Drugmakers
Experts Call for Lower GDUFA Fees for Small Generic Drugmakers
A group of healthcare attorneys and economics experts is rallying the FDA to offer lower user fees for smaller generics companies in the agency’s third iteration of the Generic Drug User Fee Act (GDUFA), arguing the move would encourage more companies to enter the generics market.